Share
Womens Health Diagnostics Market: Segmented: By Type (Accessories and Consumables, Diagnostic Tests, Diagnostic Devices), By End User (Hospitals and Clinics, Diagnostic and Imaging Centers, Homecare, Others) And Region - Global Analysis of Market Size, Share & Trends For 2019-2021 And Forecasts To 2031
Women’s Health Diagnostics Market to surpass USD 46.6 billion by 2031 from USD 22.9 billion in 2021 at a CAGR of 7.3% in the coming years, i.e., 2021-2031.
Women's health is an area of medicine dedicated to the treatment and diagnosis of diseases and ailments affecting women's health. Several women-related ailments, such as breast cancer, cervical cancer, ovarian cancer, menopause, and pregnancy, are diagnosed and monitored using women's health diagnostic methods, which include screening, testing, and monitoring. For the diagnosis of women's health-related disorders, a variety of tests are available. Medical diagnostic devices such as biopsy devices, imaging & monitoring systems, mammography systems, and other devices help to identify cancer, remove obstructions, and capture images of interior organs for disease screening and diagnosis.
Key drivers driving the growth of the women's health diagnostics market include an increase in the worldwide geriatric female population, an increase in the frequency of chronic and lifestyle disorders, and an increase in demand for point-of-care diagnostic testing. Furthermore, government initiatives to enhance women's health awareness around the world are fueling the growth of the women's health diagnostics market. The increased use of imaging techniques for diagnosis is due to the rise in novel applications of imaging techniques.
Based on Type, the Women’s Health Diagnostics Market is divided into Accessories and Consumables, Diagnostic Tests, and Diagnostic Devices. In past years, the category of the diagnostic test contributed the most to the market. The women's health diagnostics market for tests is driven by an increase in the prevalence of various health-related disorders among women, such as cancer and infertility, as well as increased awareness about women's health-related tests, high demand for point-of-care diagnostic testing, and the development of numerous diagnostic & imaging centers.
Global Women’s Health Diagnostics Market is classified on the basis of End User into Hospitals and Clinics, Diagnostic and Imaging Centers, Homecare, and Others. In previous years, the hospitals and clinics category contributed the most to the market. The growth in breast and ovarian cancer incidences has resulted in a large increase in hospitalizations.
The surge in demand for improved technologies and growing cases of heart-related disorders in women
The market is growing due to an increase in demand for improved technologies and the availability of diagnostic centers. The growth of the women's health diagnostics market is driven by an increase in the prevalence of various health-related disorders among women, such as infertility and breast cancer, high demand for point-of-care diagnostic testing, increased awareness about women's health-related tests, and the development of numerous diagnostic & imaging centers. Furthermore, an increase in healthcare spending, increased awareness of malignant tumors, and the availability of newer and more powerful diagnostic technologies are projected to promote market growth in the near future.
Rising demand for test kits due to growing cases is driving the market growth
Increased sales of test kits for home use have resulted from the rising number of instances, which is likely to fuel the market's revenue growth over the forecast period. The market is predicted to develop due to increased implementation of point-of-care diagnostic testing and an increase in the number of diagnostic and imaging equipment available globally.
High cost associated with the Women’s Health Diagnostics
The market's expansion is stifled by high-cost imaging techniques and a scarcity of competent personnel. In addition, high prices for diagnostic tests, devices, and procedures, as well as insufficient reimbursements for diagnostic testing, are projected to limit the market's growth.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Global Women’s Health Diagnostics Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The largest proportion of the market was held by North America. The rising incidences of cancer among women, the growing focus of producers of women's health diagnostic devices on expanding their presence in this region, and the rising demand for fertility testing monitors are all factors contributing to this market segment's size. Moreover, during the projected period, the increased popularity of POC diagnostics and PST procedures is expected to support the growth of this regional segment.
Impact of COVID-19 on Women’s Health Diagnostics MarketTo control and reduce the coronavirus (COVID-19) spread, more countries around the world have closed their borders and limited transportation and travel since the beginning of 2020, causing international trade and transportation to be hampered. The supply chains for women's health diagnostics were disturbed, that relatively dropped the demand for short-term due to global economic and capital market uncertainty.
| Report Attribute | Details |
| Market size value in 2021 | USD 22.9 billion |
| Revenue forecast in 2031 | USD 46.6 billion |
| Growth Rate | CAGR of 7.3% from 2021 to 2031 |
| Base year for estimation | 2020 |
| Quantitative units | Revenue in USD million and CAGR from 2021 to 2031 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Type, End User, and Region |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Key companies profiled | Siemens Healthcare Private Limited, Hologic, Inc., GE Healthcare, F. Hoffmann-La Roche Ltd., bioMérieux SA, Koninklijke Philips N.V., Abbott, and BD. |
The Women’s Health Diagnostics Market size was estimated at USD 22.9 billion in 2021 and is expected to reach 46.6 billion in 2031.
Key players: Siemens Healthcare Private Limited, Hologic, Inc., GE Healthcare, F. Hoffmann-La Roche Ltd., bioMérieux SA, Koninklijke Philips N.V., Abbott.
Diagnostics Tests segment and The hospitals and Clinics segment
Drivers: The surge in demand for improved technologies and growing cases of heart-related disorders in women, Rising demand for test kits due to growing cases is driving the market growth
Women's health is an area of medicine dedicated to the treatment and diagnosis of diseases and ailments affecting women's health. Several women-related ailments, such as breast cancer, cervical cancer, ovarian cancer, menopause, and pregnancy, are diagnosed and monitored using women's health diagnostic methods, which include screening, testing, and monitoring.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
